Michael T Dill

7PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersEnvironmental epidemiologyDeep learningCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 09, 2026
ALBI-6-A Novel Prognostic Score Combining ALBI and Interleukin-6 in Patients With HCC Treated With Atezolizumab and Bevacizumab.

|Apr 01, 2026
Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt.

Sarah Prallet, Niclas Maier, Albert Li

|Aug 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.

Nan Wei, René Michael Mathy, De-Hua Chang

|Feb 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.

Alexander Olkus, Aurelie Tomczak, Anne Katrin Berger

|Nov 18, 2018
NUAK2 is a critical YAP target in liver cancer.

Wei-Chien Yuan, Brian Pepe-Mooney, Giorgio G Galli

Pageof 2

Frequent Collaborators

1 joint publications

Han Liang

1 joint publications

Jan S Tchorz

1 joint publications

Nan Wei

1 joint publications

René Michael Mathy